1 completed, 1 withdrawn. 1 Early Phase 1, 1 Not applicable.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 1 | Completed 1 |
| Not applicable | 1 | Withdrawn 1 |
Follow Grace Shih, MD: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Use of Intrathecal Hydromorphone in Elective Cesarean Deliveries Hydromorphone, Morphine - Pain | Early Phase 1 | Completed | Grace Shih, MD | 45 | 2013-05-01 | 2019-01-03 |
| Evaluate The Effectiveness Of Fospropofol (Lusedra®) For Induction Of Anesthesia Fospropofol (Lusedra®) 6.5, Fospropofol (Lusedra®) 10, Fospropofol (Lusedra®) 12 - Interstitial Cystitis | Not applicable | Withdrawn | Grace Shih, MD | 2011-06-01 | 2012-10-03 |
Agnosia (1) · Cystitis, Interstitial (1) · Pain (1) · Respiratory Insufficiency (1)
Hydromorphone (1) · Morphine (1) · fospropofol (1)
United States (1)